Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia
2013
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis
2022 StandoutNobel
Management of hepatitis B
2007
Rescuing the bottom billion through control of neglected tropical diseases
2009 Standout
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
2008 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
PROTEINASE ACTIVITIES IN TOTAL EXTRACTS AND IN MEDIUM CONDITIONED BYACANTHAMOEBA POLYPHAGATROPHOZOITES
2000
Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy
2011
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Selenium in the maintenance and therapy of HIV-infected patients
1994
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Isolation, Identification and Increasing Importance of 'Free-Living' Amoebae Causing Human Disease
1998
Syndemics and the biosocial conception of health
2017 Standout
The Increasing Importance of Acanthamoeba Infections1
2000
A Randomized, Placebo‐Controlled Study of Rifabutin Added to a Regimen of Clarithromycin and Ethambutol for Treatment of Disseminated Infection with Mycobacterium avium Complex
1999
Immunologic correlates of protection induced by vaccination
2001
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
2007 StandoutNobel
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
NONTUBERCULOUS MYCOBACTERIAL INFECTIONS
1997
Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand
2011
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
2003
N‐acetylcysteine – passe‐partout or much ado about nothing?
2005
Safety of triazole antifungal drugs in patients with cancer
2009
Aspergillus Tracheobronchitis
2012
A Comparison of Two Regimens for the Treatment ofMycobacterium aviumComplex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin
1996
Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus
2008
Acanthamoeba Keratitis
1998
Hepatitis B virus infection
2009 Standout
Successful Treatment of Widely Disseminated Acanthamoebiasis
1999
Expanded Clinical Presentation of Community-Acquired Methicillin-Resistant Staphylococcus aureus Pneumonia
2010
Aspergillus bronchitis without significant immunocompromise
2012
Therapeutic Outcome in Invasive Aspergillosis
1996
Once Weekly Azithromycin Therapy for Prevention ofMycobacterium aviumComplex Infection in Patients with AIDS: A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Trial
1998
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Cutaneous acanthamoebiasis in AIDS
2000
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999
2000
PURIFICATION AND CHARACTERIZATION OF A SECRETORY SERINE PROTEINASE OFACANTHAMOEBA HEALYIISOLATED FROM GAE
2000
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Aspergillosis
2002
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
Efficacy of Novel Antimicrobials Against Clinical Isolates of Opportunistic Amebas
1998
Free‐living, Amphizoic and Opportunistic Amebas
1997
Prospective Randomized Trial of Four Three‐Drug Regimens in the Treatment of DisseminatedMycobacterium aviumComplex Disease in AIDS Patients: Excess Mortality Associated with High‐Dose Clarithromycin
1999
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic
1997
The Clinical Spectrum of Pulmonary Aspergillosis
2002
A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
2011
Successful Treatment of Refractory Disseminated Mycobacterium avium Complex Infection with the Addition of Linezolid and Mefloquine
2002
Pulmonary aspergillosis in acquired immune deficiency syndrome: Autopsy study of an emerging pulmonary complication of human immunodeficiency virus infection
1997
Disseminated Acanthamebiasis in a Renal Transplant Recipient with Osteomyelitis and Cutaneous Lesions: Case Report and Literature Review
2002
Graphdiyne-modified TiO2 nanofibers with osteoinductive and enhanced photocatalytic antibacterial activities to prevent implant infection
2020
Disseminated acanthamoebiasis presenting as lobular panniculitis with necrotizing vasculitis in a patient with AIDS
2001
Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream Infections
2006
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
New Rules for Clinical Trials of Patients With Acute Bacterial Skin and Skin-Structure Infections: Do Not Let the Perfect Be the Enemy of the Good
2011
Pulmonary Aspergillosis and Invasive Disease in AIDS
1998
Pharmacokinetic/Pharmacodynamic Profile of Posaconazole
2010
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Fifteen-Year Study of the Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus
2006
Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms
2008
The importance of glutathione in human disease
2003 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients<SUBTITLE>A 3-Year Randomized Trial</SUBTITLE>
2004
Early Manifestations of DisseminatedMycobacterium aviumComplex Disease: A Prospective Evaluation
1997
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
The invasive and saprophytic syndromes due toAspergillusspp.
2005
Antibody testing in aspergillosis—quo vadis?
2015
Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials
2001
Acyclic nucleoside phosphonates: Past, present and future
2006
Practice Guidelines for Diseases Caused by Aspergillus
2000
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Redox Imbalance and Its Control in HIV Infection
2002
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Cutaneous Infections Due to Acanthamoeba in Patients With Acquired Immunodeficiency Syndrome
1997
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods
1987
Azole-Based Energetic Salts
2011 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450
2011
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Conazoles
2010
Emerging S‐Scheme Photocatalyst
2021 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Invasive Candidiasis
2015 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Characterization of a Strain of Community-AssociatedMethicillin-Resistant Staphylococcus aureus WidelyDisseminated in the UnitedStates
2006
Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients?
1997
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Mycobacterial Infections in. AIDS Patients, with an Emphasis on the Mycobacterium avium Complex
1986
N-acetylcysteine for sepsis and systemic inflammatory response in adults
2012
The Crisis in Antibiotic Resistance
1992 StandoutScience
Aspergillus fumigatusand Aspergillosis
1999 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Use of a Single-Nucleotide Polymorphism Genotyping System To Demonstrate the Unique Epidemiology of Methicillin-Resistant Staphylococcus aureus in Remote Aboriginal Communities
2006
Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
2012
Granulomatous Amebic Encephalitis in a Patient with AIDS: Isolation of Acanthamoeba sp. Group II from Brain Tissue and Successful Treatment with Sulfadiazine and Fluconazole
2000
Oral drug therapy for multiple neglected tropical diseases: a systematic review.
2007
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Tracheobronchial Manifestations ofAspergillusInfections
2011
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility ofAspergillus fumigatus
1996
Methicillin-resistant staphylococci
1988
Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial
2007
Cultivation of Pathogenic and Opportunistic Free-Living Amebas
2002
Subgenus classification of Acanthamoeba by riboprinting
1998
Isavuconazole: A New and Promising Antifungal Triazole for the Treatment of Invasive Fungal Infections
2008
Horizontal Transmission of Candida parapsilosis Candidemia in a Neonatal Intensive Care Unit
2002
Activity of Daptomycin Alone and in Combination with Rifampin and Gentamicin against Staphylococcus aureus Assessed by Time-Kill Methodology
2007
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
2009
Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
2005
Amebic Osteomyelitis in a Child with Acquired Immunodeficiency Syndrome: A Case Report
1998
Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients
1996
Acanthamoebaspp. as Agents of Disease in Humans
2003 Standout
Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion
2019
Development of an Acanthamoeba‐specific Reverse Dot‐Blot and the Discovery of a New Ribotype
2001
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
The Mycobacterium avium complex
1993
Correlates of Protection Induced by Vaccination
2010 Standout
Works of Stan Deresinski being referenced
When sepsis persists: a review of MRSA bacteraemia salvage therapy
2015
Principles of Antibiotic Therapy in Severe Infections: Optimizing the Therapeutic Approach by Use of Laboratory and Clinical Data
2007
Bacteremia due to Methicillin-Resistant Staphylococcus aureus
2016
Tenofovir Disoproxil Fumarate
2003
Transient Bacteremia Due to Mycobacterium avium Complex in Patients with AIDS
1994
Ulcerative and Plaque-Like Tracheobronchitis Due to Infection with Aspergillus in Patients with AIDS
1993
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
2005
The Individual Microbiologic Effect of Three Antimycobacterial Agents, Clofazimine, Ethambutol, and Rifampin, on Mycobacterium avium Complex Bacteremia in Patients with AIDS
1994
Immunomodulatory Treatment of Mycobacterium avium Complex Bacteremia in Patients with AIDS by Use of Recombinant Granulocyte-Macrophage Colony-Stimulating Factor
1998
Posaconazole: A Broad-Spectrum Triazole Antifungal Agent
2007
Progressive Immunodeficiency Due to Infection with Human Immunodeficiency Virus Does Not Lead to Waning Immunity to Measles in a Cohort of Homosexual Men
1994
N‐acetylcysteine replenishes glutathione in HIV infection
2000
Disseminated Acanthamoeba Infection in Patients with AIDS: Case Reports and Review
1995
Early identification of neutropenic patients at risk of gram-positive bacteraemia and the impact of empirical administration of vancomycin
1996
Flubendazole and mebendazole in the treatment of trichuriasis and other helminthiases.
1981
Bone and joint coccidioidomycosis treated with miconazole.
1979
Norfloxacin for prevention of bacterial infections in granulocytopenic patients
1987
Reply to Cornely and Ullmann and to Jain and Pottinger
2008
Genotypic analysis of pseudoepidemic due to contamination of Hanks' balanced salt solution with Candida parapsilosis
1995
Reproducibility of lysis-centrifugation cultures for quantification of Mycobacterium avium complex bacteremia
1993
Norovirus
2015
CD20 expression is increased on B lymphocytes from HIV-infected individuals.
1992
Rapid radiometric method for determining drug susceptibility of Mycobacterium avium-intracellulare
1981